Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment

  • Signal Transduct Target Ther. 2023 Mar 1;8(1):91. doi: 10.1038/s41392-022-01292-5.
Binbin Cheng  #  1  2 ,  Wei Wang  #  2 ,  Ting Liu  2 ,  Hao Cao  2 ,  Wei Pan  3 ,  Yao Xiao  2 ,  Shuwen Liu  4 ,  Jianjun Chen  5
Affiliations
  • 1. School of Medicine, Hubei Polytechnic University, Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Huangshi, 435003, China.
  • 2. School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, 510515, China.
  • 3. Department of Cardiology, The Sixth Affiliated Hospital, South China University of Technology, Nanhai people's Hospital, Foshan, Guangdong, 528200, China.
  • 4. School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, 510515, China. [email protected].
  • 5. School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, 510515, China. [email protected].
  • # Contributed equally.
PMID: 36854661 DOI: 10.1038/s41392-022-01292-5
Products